VA CoronavirUs Research and Efficacy Studies-1
NCT04539275
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
75
Enrollment
FED
Sponsor class
Stopped
DMC recommended early termination of enrollment
Conditions
COVID-19
Interventions
DRUG:
Convalescent Plasma
OTHER:
Masked Saline Placebo
Sponsor
VA Office of Research and Development